(R)-4-Isopropyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole
98%
- Product Code: 37678
CAS:
2010973-00-7
| Molecular Weight: | 258.2396 g./mol | Molecular Formula: | C₁₂H₁₃F₃N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of biologically active compounds. Its structure, featuring a trifluoromethylpyridine moiety and a dihydrooxazole ring, makes it valuable for developing drugs targeting specific enzymes or receptors. It is often employed in the creation of small molecule inhibitors, particularly for applications in oncology and inflammation treatment. The compound’s chiral center (R-configuration) is crucial for its role in producing enantioselective pharmaceuticals, ensuring high specificity and efficacy in drug-target interactions. Additionally, it is used in research settings to explore novel therapeutic pathways and optimize drug candidates for improved pharmacokinetic properties.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | $49.34 |
+
-
|
(R)-4-Isopropyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole
This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of biologically active compounds. Its structure, featuring a trifluoromethylpyridine moiety and a dihydrooxazole ring, makes it valuable for developing drugs targeting specific enzymes or receptors. It is often employed in the creation of small molecule inhibitors, particularly for applications in oncology and inflammation treatment. The compound’s chiral center (R-configuration) is crucial for its role in producing enantioselective pharmaceuticals, ensuring high specificity and efficacy in drug-target interactions. Additionally, it is used in research settings to explore novel therapeutic pathways and optimize drug candidates for improved pharmacokinetic properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :